Background: Calcification of renal allografts has been reported in adult kidney transplant (KTx) recipients with a widely differing prevalence (2–60%). Persistent hyperparathyroidism, hypercalcemia and concomitant hypercalciuria were identified as major risk factors. We aimed to determine the prevalence and risk factors for such calcifications in children. Methods: We investigated histological stains of routine graft biopsies from pediatric KTx patients for renal calcifications and determined the urinary excretion of lithogenic (oxalate, calcium) and stone-inhibitory substances (citrate). Results: In our series of transplant patients, tubular calcification was found in 16 of the 36 (44.4%) KTx biopsies by an additional Kossa stain. This transplant calcification was not associated with any singular risk factor and was not correlated to a worse transplant outcome. Conclusion: Although our pediatric findings confirm the reported incidence rates of KTx calcification in adults, we could neither identify hypercalciuria as a risk factor nor confirm any negative influence on graft function. However, long-term studies are clearly needed to prove or disprove a negative impact of calcifications on graft function.

Keywords:
Kidney transplant, Renal calcification, Hyperparathyroidism, Hypercalcemia, Hypercalciuria
1.
Meier-Kriesche HU, Schold JD, Kaplan B: Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004;4:1289–1295.
2.
Chapman JR, O’Connell PJ, Nankivell BJ: Chronic renal allograft dysfunction. J Am Soc Nephrol 2005;16:3015–3026.
3.
Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 2003;349:2326–2333.
4.
Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H, Schwarz A: Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant 2005;5:1934–1941.
5.
Abbott KC, Schenkman N, Swanson SJ, Agodoa LY: Hospitalized nephrolithiasis after renal transplantation in the United States. Am J Transplant 2003;3:465–470.
6.
Schwarz A, Mengel M, Gwinner W, Eisenberger U, Hiss M, Radermacher J, Fiebeler A, Abou-Rebyeh F, Haller H: Protocol biopsy program after renal transplantation: structure and first results. Transplant Proc 2002;34:2238–2239.
7.
Verhulst A, Asselman M, De Naeyer S, Vervaet BA, Mengel M, Gwinner W, D’Haese PC, Verkoelen CF, De Broe ME: Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int 2005;68:1643–1647.
8.
Beck B, Hoppe B: Pediatric aspects of nephrolithiasis and nephrocalcinosis; in Chaussy HG, Jocham D, Koehmann KU, Wilbert D (eds): Therapeutic Energy Applications in Urology. Heidelberg, Thieme, 2005, pp 86–91.
9.
Stapenhorst L, Sassen R, Beck B, Laube N, Hesse A, Hoppe B: Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation. Pediatr Nephrol 2005;20:652–656.
10.
Werness PG, Brown CM, Smith LH, Finlayson B: EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 1985;134:1242–1244.
11.
Hoppe B, Jahnen A, Bach D, Hesse A: Urinary calcium-oxalate saturation in healthy infants and children. J Urol 1997;158:557–559.
12.
Erbagci A, Erbagci AB, Yilmaz M, Yagci F, Tarakcioglu M, Yurtseven C, Koyluoglu O, Sarica K: Pediatric urolithiasis: evaluation of risk factors in 95 children. Scand J Urol Nephrol 2003;37:129–133.
13.
Habbig S, Krax J, Beck B, Feldkötter M, Taylan C, Körber F, Hoppe B: Is hypercalciuria really the most important risk factor for nephrolithiasis in children? Pediatr Nephrol 2008;23:1605 (Abstract).
14.
Marbet U, Graf U, Mihatsch MJ, Gratwohl A, Müller W, Thiel G: Renale Nebenwirkungen der Therapie mit Cyclosporin A bei chronischer Polyarthritis und nach Knochenmarkstransplantation. Schweiz Med Wochenschr 1980;110:2017–2020.
15.
Mihatsch MJ, Thiel G, Basler V, Ryffel B, Landmann J, von Overbeck J, Zollinger HU: Morphological patterns in cyclosporine-treated renal transplant recipients. Transplant Proc 1985;17(4 suppl 1):101–116.
16.
Mihatsch MJ, Ryffel B, Hermle M, Brunner FP, Thiel G: Morphology of cyclosporine nephrotoxicity in the rat. Clin Nephrol 1986;25:S2–S8.
17.
Boom H, Mallat MJ, de Fijter JW, Paul LC, Bruijn JA, van Es LA: Calcium levels as a risk factor for delayed graft function. Transplantation 2004;77:868–873.
18.
Pinheiro HS, Câmara NO, Osaki KS, De Moura LA, Pacheco-Silva A: Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival. Am J Transplant 2005;5:323–329.
19.
Hoppe B, Kemper M: Diagnostic evaluation of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol 2008 Dec 23 [Epub ahead of print].
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.